Back to search
🇺🇸

United States · US · US:83831-124_303c41a6-c142-4cd2-b133-9e610845d5bf

AVGEMSI

In shortageOrange BookUNIISPLATC L01BC05

Last synced from FDA National Drug Code directory (United States) on

Identification

ManufacturerAvyxa Pharma, LLC
CountryUS (United States)
ATC codeL01BC05
Dispensing
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026

Packs · 1

  • ndc11
    8383112401
    1 VIAL, MULTI-DOSE in 1 CARTON (83831-124-01) / 52.6 mL in 1 VIAL, MULTI-DOSE

Annotations

UNII (FDA Substance ID)
U347PV74IL
GEMCITABINE HYDROCHLORIDE
RxCUI 236234
Orange Book
N219920
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Gemcitabine Hydrochloride Injection
Raw payload (JSON)
{
  "unii": {
    "unii": "U347PV74IL",
    "rxcui": "236234",
    "inchikey": "OKKDEIYWILRZIA-OSZBKLCCSA-N",
    "display_name": "GEMCITABINE HYDROCHLORIDE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "e11eeff7-bcaf-4bf1-8da8-88138e01af84": {
      "match": "brand_token",
      "title": "AVGEMSI (GEMCITABINE) INJECTION, SOLUTION [AVYXA PHARMA, LLC]",
      "spl_version": "3",
      "published_date": "2025-08-07"
    }
  },
  "productid": "83831-124_303c41a6-c142-4cd2-b133-9e610845d5bf",
  "productndc": "83831-124",
  "dosage_form": "INJECTION, SOLUTION",
  "orange_book": {
    "appl_no": "219920",
    "products": [
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "EQ 200MG BASE/5.26ML (EQ 38MG BASE/ML)",
        "product_no": "001",
        "approval_date": "Jun 27, 2025"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": null,
        "strength": "EQ 1GM BASE/26.3ML (EQ 38MG BASE/ML)",
        "product_no": "002",
        "approval_date": "Jun 27, 2025"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": null,
        "strength": "EQ 2GM BASE/52.6ML (EQ 38MG BASE/ML)",
        "product_no": "003",
        "approval_date": "Jun 27, 2025"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "GEMCITABINE HYDROCHLORIDE",
  "shortage_reason": "Gemcitabine Hydrochloride Injection",
  "shortage_status": "current",
  "proprietary_name": "AVGEMSI",
  "active_ingred_unit": "mg/mL",
  "application_number": "NDA219920",
  "marketing_category": "NDA",
  "nonproprietary_name": "Gemcitabine",
  "start_marketing_date": "20250803",
  "active_numerator_strength": "38"
}

Related drugs

Other records sharing ATC code L01BC05.

Access this data programmatically

Query AVGEMSI and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.